Cargando…

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients

Endocrine therapy is a key treatment strategy to control or eradicate hormone-responsive breast cancer. However, resistance to endocrine therapy leads to breast cancer relapse. The recent extension of adjuvant tamoxifen treatment up to 10 years actualizes the need for identifying biological markers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egeland, Nina G., Lunde, Siri, Jonsdottir, Kristin, Lende, Tone H., Cronin-Fenton, Deirdre, Gilje, Bjørnar, Janssen, Emiel A. M., Søiland, Håvard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632748/ https://www.ncbi.nlm.nih.gov/pubmed/26473850 http://dx.doi.org/10.3390/ijms161024243

Ejemplares similares

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients — an explorative study
por: Lende, Tone Hoel, et al.
Publicado: (2019)

Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
por: Helland, Thomas, et al.
Publicado: (2020)

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
por: Egeland, Nina Gran, et al.
Publicado: (2020)

Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
por: Chen, Yuanhuang, et al.
Publicado: (2021)

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients
por: Klebaner, Daniella, et al.
Publicado: (2017)

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study
por: Søiland, Håvard, et al.
Publicado: (2022)

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
por: Egeland, Nina Gran, et al.
Publicado: (2020)

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial
por: Lende, Tone Hoel, et al.
Publicado: (2019)

Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review
por: Eliassen, Finn Magnus, et al.
Publicado: (2023)

Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients
por: Tjensvoll, Kjersti, et al.
Publicado: (2019)

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
por: Helland, Thomas, et al.
Publicado: (2017)

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2021)

Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer
por: Helland, Thomas, et al.
Publicado: (2021)

Next-of-kin involvement in improving hospital cancer care quality and safety – a qualitative cross-case study as basis for theory development
por: Bergerød, Inger Johanne, et al.
Publicado: (2018)

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment
por: Lien, Ernst A., et al.
Publicado: (2013)

Developing a Next-of-Kin Involvement Guide in Cancer Care—Results From a Consensus Process
por: Bergerød, Inger J., et al.
Publicado: (2021)

Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system – the Stavanger experience
por: Viste, Eirik, et al.
Publicado: (2020)

Success Predictors of Adjuvant Chemotherapy in Node-Negative Breast Cancer Patients Under 55 years(1)
por: Janssen, Emiel A. M., et al.
Publicado: (2006)

Emerging Concepts of Apolipoprotein D with Possible Implications for Breast Cancer
por: Søiland, Håvard, et al.
Publicado: (2007)

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics
por: Oltedal, Satu, et al.
Publicado: (2018)

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers
por: Jonsdottir, Kristin, et al.
Publicado: (2012)

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients
por: Egeland, Nina Gran, et al.
Publicado: (2019)

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset
por: Damkier, Per, et al.
Publicado: (2017)

Hyperthyroidism or hypothyroidism and gastrointestinal cancer risk: a Danish nationwide cohort study
por: Kirkegård, Jakob, et al.
Publicado: (2018)

Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer
por: Dragvoll, Ida, et al.
Publicado: (2022)

The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells
por: Helland, Thomas, et al.
Publicado: (2015)

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer
por: Lapin, Morten, et al.
Publicado: (2023)

A burning question: does hot green tea drinking increase the risk of esophageal squamous cell carcinoma?
por: Cronin-Fenton, Deirdre
Publicado: (2018)

Comparing the Prognostic Value of PTEN and Akt Expression with the Mitotic Activity Index in Adjuvant Chemotherapy-Treated Node-Negative Breast Cancer patients aged <55 years
por: Janssen, Emiel A. M., et al.
Publicado: (2007)

Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer
por: Maliniak, Maret L., et al.
Publicado: (2021)

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
por: Janssen, Emiel A. M., et al.
Publicado: (2009)

Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction
por: Gidlöf, Olof, et al.
Publicado: (2013)

Traumatic experiences and PTSD symptoms in substance use disorder: A comparison of recovered versus current users
por: Belfrage, Anna, et al.
Publicado: (2022)

Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial
por: DeCensi, Andrea, et al.
Publicado: (2021)

Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway
por: Bjorland, Line Sagerup, et al.
Publicado: (2021)

miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer
por: Ben-Elazar, Shay, et al.
Publicado: (2021)

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram
por: Lash, T L, et al.
Publicado: (2008)

Differential expression of microRNAs as predictors of glioblastoma phenotypes
por: Bradley, Barrie S, et al.
Publicado: (2014)

Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer
por: Montagna, Emilia, et al.
Publicado: (2021)

MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*
por: Lü, Mingrong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h8g6cia9qvgott1hu0b9rse7nj